|
chr9_+_132961723
|
2.560
|
|
AIF1L
|
allograft inflammatory factor 1-like
|
|
chr9_+_132961683
|
1.942
|
NM_001185095
NM_001185096
NM_031426
|
AIF1L
|
allograft inflammatory factor 1-like
|
|
chr22_-_19122107
|
1.916
|
NM_153334
NM_182895
|
SCARF2
|
scavenger receptor class F, member 2
|
|
chr22_-_19122047
|
1.676
|
|
SCARF2
|
scavenger receptor class F, member 2
|
|
chr1_+_181259317
|
1.367
|
|
|
|
|
chr2_+_10101081
|
1.331
|
NM_003597
NM_001177716
|
KLF11
|
Kruppel-like factor 11
|
|
chr8_+_1699418
|
1.292
|
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
|
chr12_-_105165805
|
1.279
|
NM_006825
|
CKAP4
|
cytoskeleton-associated protein 4
|
|
chr19_-_59676153
|
1.185
|
NM_145057
|
CDC42EP5
|
CDC42 effector protein (Rho GTPase binding) 5
|
|
chr8_+_22513043
|
1.142
|
NM_001013842
NM_001198827
NM_173686
|
C8orf58
|
chromosome 8 open reading frame 58
|
|
chr19_-_51168396
|
1.114
|
NM_002516
|
NOVA2
|
neuro-oncological ventral antigen 2
|
|
chr20_-_30534848
|
1.110
|
NM_080616
|
C20orf112
|
chromosome 20 open reading frame 112
|
|
chr7_-_107883929
|
1.061
|
NM_001193582
NM_001193583
NM_001193584
NM_005010
|
NRCAM
|
neuronal cell adhesion molecule
|
|
chr1_-_223907283
|
1.003
|
NM_001008493
NM_018212
|
ENAH
|
enabled homolog (Drosophila)
|
|
chr15_-_76890626
|
0.911
|
NM_014272
|
ADAMTS7
|
ADAM metallopeptidase with thrombospondin type 1 motif, 7
|
|
chr4_+_3264509
|
0.908
|
|
RGS12
|
regulator of G-protein signaling 12
|
|
chr7_-_28186671
|
0.878
|
|
JAZF1
|
JAZF zinc finger 1
|
|
chr22_+_18081968
|
0.866
|
NM_002688
|
SEPT5
|
septin 5
|
|
chr17_-_74433048
|
0.838
|
NM_003255
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
chr6_+_11646472
|
0.828
|
NM_001100829
|
TMEM170B
|
transmembrane protein 170B
|
|
chr7_-_102044419
|
0.817
|
NM_001079877
NM_006989
|
RASA4
|
RAS p21 protein activator 4
|
|
chr6_-_42527760
|
0.817
|
NM_033502
|
TRERF1
|
transcriptional regulating factor 1
|
|
chrX_-_1291526
|
0.795
|
NM_001012288
NM_022148
|
CRLF2
|
cytokine receptor-like factor 2
|
|
chr17_-_74432800
|
0.787
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
chr2_+_54536780
|
0.776
|
NM_003128
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
chr6_+_37245860
|
0.767
|
NM_002648
|
PIM1
|
pim-1 oncogene
|
|
chr12_-_47468985
|
0.762
|
NM_020983
|
ADCY6
|
adenylate cyclase 6
|
|
chr1_-_32574185
|
0.756
|
NM_023009
|
MARCKSL1
|
MARCKS-like 1
|
|
chr22_+_21742727
|
0.749
|
|
GNAZ
|
guanine nucleotide binding protein (G protein), alpha z polypeptide
|
|
chr4_+_145786622
|
0.739
|
NM_022475
|
HHIP
|
hedgehog interacting protein
|
|
chr1_-_1465602
|
0.734
|
NM_001114748
|
C1orf70
|
chromosome 1 open reading frame 70
|
|
chr8_+_1699276
|
0.722
|
NM_018941
|
CLN8
|
ceroid-lipofuscinosis, neuronal 8 (epilepsy, progressive with mental retardation)
|
|
chr17_-_74432671
|
0.721
|
|
TIMP2
|
TIMP metallopeptidase inhibitor 2
|
|
chr12_+_50271283
|
0.715
|
NM_014191
|
SCN8A
|
sodium channel, voltage gated, type VIII, alpha subunit
|
|
chr1_+_113734997
|
0.698
|
NM_001142782
NM_152900
|
MAGI3
|
membrane associated guanylate kinase, WW and PDZ domain containing 3
|
|
chr17_+_77582774
|
0.698
|
NM_005052
|
RAC3
|
ras-related C3 botulinum toxin substrate 3 (rho family, small GTP binding protein Rac3)
|
|
chrX_-_19815586
|
0.689
|
NM_031892
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
chr22_-_17659183
|
0.674
|
NM_001835
NM_007098
|
CLTCL1
|
clathrin, heavy chain-like 1
|
|
chr8_+_142207866
|
0.673
|
NM_014957
|
DENND3
|
DENN/MADD domain containing 3
|
|
chr2_+_25118417
|
0.673
|
NM_014971
|
EFR3B
|
EFR3 homolog B (S. cerevisiae)
|
|
chr1_+_199884072
|
0.654
|
NM_020443
|
NAV1
|
neuron navigator 1
|
|
chr12_+_69046241
|
0.651
|
NM_014505
|
KCNMB4
|
potassium large conductance calcium-activated channel, subfamily M, beta member 4
|
|
chr6_+_44346457
|
0.650
|
NM_001137560
|
TMEM151B
|
transmembrane protein 151B
|
|
chr1_-_6480035
|
0.643
|
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
chr22_-_21231421
|
0.641
|
NM_206955
NM_206956
NM_006115
NM_206953
NM_206954
|
PRAME
|
preferentially expressed antigen in melanoma
|
|
chr1_+_181258952
|
0.636
|
NM_002293
|
LAMC1
|
laminin, gamma 1 (formerly LAMB2)
|
|
chr7_-_27120015
|
0.634
|
|
HOXA3
|
homeobox A3
|
|
chr7_-_94123308
|
0.632
|
|
SGCE
|
sarcoglycan, epsilon
|
|
chr6_+_43151922
|
0.608
|
NM_002821
NM_152880
NM_152881
NM_152882
|
PTK7
|
PTK7 protein tyrosine kinase 7
|
|
chr1_+_6767968
|
0.605
|
NM_001195563
NM_015215
|
CAMTA1
|
calmodulin binding transcription activator 1
|
|
chr22_+_40107878
|
0.603
|
NM_003216
|
TEF
|
thyrotrophic embryonic factor
|
|
chr12_-_103055924
|
0.599
|
NM_006166
|
NFYB
|
nuclear transcription factor Y, beta
|
|
chrX_+_152413540
|
0.597
|
NM_001711
|
BGN
|
biglycan
|
|
chr8_+_146248634
|
0.593
|
|
C8orf33
|
chromosome 8 open reading frame 33
|
|
chr19_+_47480445
|
0.592
|
NM_015125
|
CIC
|
capicua homolog (Drosophila)
|
|
chr9_-_131845277
|
0.590
|
NM_015033
|
FNBP1
|
formin binding protein 1
|
|
chr7_-_526005
|
0.581
|
NM_002607
NM_033023
|
PDGFA
|
platelet-derived growth factor alpha polypeptide
|
|
chr8_+_144706699
|
0.580
|
NM_001166237
|
GSDMD
|
gasdermin D
|
|
chr21_+_46226072
|
0.562
|
NM_001848
|
COL6A1
|
collagen, type VI, alpha 1
|
|
chr6_-_31977747
|
0.558
|
NM_181842
|
ZBTB12
|
zinc finger and BTB domain containing 12
|
|
chr7_-_158073121
|
0.555
|
NM_002847
NM_130842
NM_130843
|
PTPRN2
|
protein tyrosine phosphatase, receptor type, N polypeptide 2
|
|
chr7_-_28186867
|
0.555
|
NM_175061
|
JAZF1
|
JAZF zinc finger 1
|
|
chr7_+_143683365
|
0.553
|
NM_005435
|
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5
|
|
chr9_-_131845077
|
0.552
|
|
FNBP1
|
formin binding protein 1
|
|
chr9_-_122679387
|
0.552
|
NM_001009936
NM_015651
|
PHF19
|
PHD finger protein 19
|
|
chr7_-_102044374
|
0.548
|
|
RASA4
|
RAS p21 protein activator 4
|
|
chr16_+_29730909
|
0.548
|
NM_145239
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
chr7_-_143622188
|
0.545
|
|
ARHGEF5
|
Rho guanine nucleotide exchange factor (GEF) 5
|
|
chr7_+_73080422
|
0.541
|
|
ELN
|
elastin
|
|
chr3_+_37878647
|
0.541
|
NM_001008392
NM_005808
|
CTDSPL
|
CTD (carboxy-terminal domain, RNA polymerase II, polypeptide A) small phosphatase-like
|
|
chr19_+_40958206
|
0.540
|
NM_001172630
NM_052948
|
ARHGAP33
|
Rho GTPase activating protein 33
|
|
chr19_+_14405216
|
0.538
|
|
PKN1
|
protein kinase N1
|
|
chr9_-_129557373
|
0.537
|
NM_001142534
NM_001142533
|
SH2D3C
|
SH2 domain containing 3C
|
|
chr17_-_41018291
|
0.535
|
|
|
|
|
chr1_-_6480058
|
0.534
|
NM_001042663
|
PLEKHG5
|
pleckstrin homology domain containing, family G (with RhoGef domain) member 5
|
|
chr7_+_73080362
|
0.533
|
NM_000501
NM_001081752
NM_001081753
NM_001081754
NM_001081755
|
ELN
|
elastin
|
|
chr11_+_65049152
|
0.532
|
|
SCYL1
|
SCY1-like 1 (S. cerevisiae)
|
|
chr15_-_62854749
|
0.529
|
NM_194272
|
RBPMS2
|
RNA binding protein with multiple splicing 2
|
|
chr7_+_90063543
|
0.528
|
|
CDK14
|
cyclin-dependent kinase 14
|
|
chr2_+_54537842
|
0.522
|
|
SPTBN1
|
spectrin, beta, non-erythrocytic 1
|
|
chr7_-_94123413
|
0.522
|
NM_001099400
NM_001099401
NM_003919
|
SGCE
|
sarcoglycan, epsilon
|
|
chr7_+_73080404
|
0.520
|
|
ELN
|
elastin
|
|
chr1_+_199884152
|
0.519
|
|
NAV1
|
neuron navigator 1
|
|
chr17_+_4683280
|
0.518
|
NM_001024937
NM_015716
NM_153827
NM_170663
|
MINK1
|
misshapen-like kinase 1
|
|
chr17_+_1906262
|
0.517
|
NM_001098202
|
HIC1
|
hypermethylated in cancer 1
|
|
chr2_+_85834111
|
0.516
|
NM_032827
|
ATOH8
|
atonal homolog 8 (Drosophila)
|
|
chr10_-_49483002
|
0.515
|
NM_021226
|
ARHGAP22
|
Rho GTPase activating protein 22
|
|
chr19_-_55914837
|
0.515
|
|
|
|
|
chr22_-_49042065
|
0.515
|
NM_002969
|
MAPK12
|
mitogen-activated protein kinase 12
|
|
chr2_+_64534774
|
0.513
|
NM_014181
|
HSPC159
|
galectin-related protein
|
|
chr8_+_31010319
|
0.511
|
NM_000553
|
WRN
|
Werner syndrome, RecQ helicase-like
|
|
chr6_-_112301123
|
0.510
|
NM_002037
|
FYN
|
FYN oncogene related to SRC, FGR, YES
|
|
chr6_+_31190505
|
0.510
|
NM_014068
|
PSORS1C1
|
psoriasis susceptibility 1 candidate 1
|
|
chr15_-_53822468
|
0.509
|
NM_173814
|
PRTG
|
protogenin
|
|
chr17_-_17667580
|
0.507
|
|
SREBF1
|
sterol regulatory element binding transcription factor 1
|
|
chr20_-_30535045
|
0.505
|
|
C20orf112
|
chromosome 20 open reading frame 112
|
|
chr7_-_94123362
|
0.504
|
|
SGCE
|
sarcoglycan, epsilon
|
|
chr5_-_1165106
|
0.501
|
NM_006598
|
SLC12A7
|
solute carrier family 12 (potassium/chloride transporters), member 7
|
|
chr7_+_73080387
|
0.500
|
|
ELN
|
elastin
|
|
chr1_-_202387532
|
0.499
|
|
ETNK2
|
ethanolamine kinase 2
|
|
chr22_+_19649417
|
0.497
|
NM_001018060
NM_144704
|
AIFM3
|
apoptosis-inducing factor, mitochondrion-associated, 3
|
|
chr11_+_65049102
|
0.497
|
NM_001048218
NM_020680
|
SCYL1
|
SCY1-like 1 (S. cerevisiae)
|
|
chr20_-_62181231
|
0.497
|
NM_005873
|
RGS19
|
regulator of G-protein signaling 19
|
|
chr7_-_143622233
|
0.495
|
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35
|
|
chr20_-_47618059
|
0.489
|
NM_000961
|
PTGIS
|
prostaglandin I2 (prostacyclin) synthase
|
|
chr15_-_58671929
|
0.488
|
NM_134262
|
RORA
|
RAR-related orphan receptor A
|
|
chrX_-_19815526
|
0.486
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
chr7_-_27136876
|
0.476
|
NM_002141
|
HOXA4
|
homeobox A4
|
|
chr6_+_41714171
|
0.474
|
NM_005586
|
MDFI
|
MyoD family inhibitor
|
|
chr7_+_44110470
|
0.471
|
NM_001129
|
AEBP1
|
AE binding protein 1
|
|
chr7_-_143523582
|
0.467
|
NM_001003702
|
ARHGEF35
|
Rho guanine nucleotide exchange factor (GEF) 35
|
|
chr7_+_44110527
|
0.463
|
|
AEBP1
|
AE binding protein 1
|
|
chr15_-_19221463
|
0.460
|
|
|
|
|
chr2_+_173000590
|
0.458
|
|
ITGA6
|
integrin, alpha 6
|
|
chr1_+_200124412
|
0.458
|
NM_198149
|
SHISA4
|
shisa homolog 4 (Xenopus laevis)
|
|
chr1_+_3531410
|
0.456
|
NM_182752
|
TPRG1L
|
tumor protein p63 regulated 1-like
|
|
chr11_+_63829616
|
0.455
|
NM_004451
|
ESRRA
|
estrogen-related receptor alpha
|
|
chr5_+_92946348
|
0.454
|
|
NR2F1
|
nuclear receptor subfamily 2, group F, member 1
|
|
chrX_+_111212908
|
0.453
|
NM_001004308
|
ZCCHC16
|
zinc finger, CCHC domain containing 16
|
|
chr12_+_50104859
|
0.452
|
NM_001039960
NM_004858
|
SLC4A8
|
solute carrier family 4, sodium bicarbonate cotransporter, member 8
|
|
chr19_-_8581559
|
0.452
|
NM_030957
|
ADAMTS10
|
ADAM metallopeptidase with thrombospondin type 1 motif, 10
|
|
chr21_-_44485269
|
0.451
|
|
ICOSLG
|
inducible T-cell co-stimulator ligand
|
|
chr9_+_127549437
|
0.451
|
NM_006195
|
PBX3
|
pre-B-cell leukemia homeobox 3
|
|
chr22_+_19649460
|
0.450
|
|
AIFM3
|
apoptosis-inducing factor, mitochondrion-associated, 3
|
|
chrX_-_152749190
|
0.450
|
NM_032512
|
PDZD4
|
PDZ domain containing 4
|
|
chr7_+_73136254
|
0.449
|
|
LIMK1
|
LIM domain kinase 1
|
|
chr7_+_128257698
|
0.449
|
NM_001127487
NM_001458
|
FLNC
|
filamin C, gamma
|
|
chr22_-_35835548
|
0.448
|
|
TMPRSS6
|
transmembrane protease, serine 6
|
|
chr7_-_127833231
|
0.447
|
NM_001142573
NM_001142574
NM_001142575
|
IMPDH1
|
IMP (inosine 5'-monophosphate) dehydrogenase 1
|
|
chr19_+_40213431
|
0.446
|
NM_001037
NM_199037
|
SCN1B
|
sodium channel, voltage-gated, type I, beta
|
|
chr16_+_29731058
|
0.446
|
|
PRRT2
|
proline-rich transmembrane protein 2
|
|
chr16_+_80036275
|
0.444
|
NM_198390
|
CMIP
|
c-Maf-inducing protein
|
|
chr2_-_179837490
|
0.441
|
NM_178123
|
SESTD1
|
SEC14 and spectrin domains 1
|
|
chr19_-_7896974
|
0.440
|
NM_206833
|
CTXN1
|
cortexin 1
|
|
chr16_+_84202515
|
0.439
|
NM_001134473
|
KIAA0182
|
KIAA0182
|
|
chr22_-_17303654
|
0.438
|
|
PRODH
|
proline dehydrogenase (oxidase) 1
|
|
chr7_+_101861007
|
0.431
|
|
ORAI2
|
ORAI calcium release-activated calcium modulator 2
|
|
chr6_-_143307976
|
0.431
|
NM_006734
|
HIVEP2
|
human immunodeficiency virus type I enhancer binding protein 2
|
|
chr9_+_132874324
|
0.430
|
NM_006059
|
LAMC3
|
laminin, gamma 3
|
|
chr5_+_52320660
|
0.429
|
NM_002203
|
ITGA2
|
integrin, alpha 2 (CD49B, alpha 2 subunit of VLA-2 receptor)
|
|
chr20_-_62181588
|
0.424
|
NM_001039467
|
RGS19
|
regulator of G-protein signaling 19
|
|
chr19_+_15079141
|
0.424
|
NM_033025
|
SYDE1
|
synapse defective 1, Rho GTPase, homolog 1 (C. elegans)
|
|
chr22_-_19716837
|
0.423
|
NM_004173
|
SLC7A4
|
solute carrier family 7 (cationic amino acid transporter, y+ system), member 4
|
|
chr4_-_83702123
|
0.421
|
NM_001080506
|
TMEM150C
|
transmembrane protein 150C
|
|
chr14_-_94855848
|
0.419
|
NM_024734
|
CLMN
|
calmin (calponin-like, transmembrane)
|
|
chr3_-_38666122
|
0.417
|
NM_000335
NM_001099404
NM_001099405
NM_198056
NM_001160160
NM_001160161
|
SCN5A
|
sodium channel, voltage-gated, type V, alpha subunit
|
|
chr7_-_142816019
|
0.417
|
NM_005232
|
EPHA1
|
EPH receptor A1
|
|
chr17_+_63252704
|
0.416
|
|
BPTF
|
bromodomain PHD finger transcription factor
|
|
chr17_+_71097147
|
0.413
|
|
MYO15B
|
myosin XVB pseudogene
|
|
chr19_-_56178882
|
0.413
|
NM_139277
NM_005046
|
KLK7
|
kallikrein-related peptidase 7
|
|
chr17_-_76622967
|
0.412
|
|
FLJ90757
|
hypothetical LOC440465
|
|
chr16_+_6009095
|
0.410
|
NM_001142333
NM_018723
|
RBFOX1
|
RNA binding protein, fox-1 homolog (C. elegans) 1
|
|
chr9_+_135314907
|
0.409
|
NM_001135775
NM_017586
|
C9orf7
|
chromosome 9 open reading frame 7
|
|
chr22_-_17546234
|
0.408
|
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
|
chr17_+_78630793
|
0.407
|
NM_001004431
|
METRNL
|
meteorin, glial cell differentiation regulator-like
|
|
chr5_-_38592439
|
0.407
|
NM_001127671
|
LIFR
|
leukemia inhibitory factor receptor alpha
|
|
chr6_-_33393471
|
0.406
|
NM_005453
|
ZBTB22
|
zinc finger and BTB domain containing 22
|
|
chr22_+_21742364
|
0.399
|
NM_002073
|
GNAZ
|
guanine nucleotide binding protein (G protein), alpha z polypeptide
|
|
chr6_+_17501589
|
0.399
|
NM_006366
|
CAP2
|
CAP, adenylate cyclase-associated protein, 2 (yeast)
|
|
chr19_-_15421761
|
0.397
|
NM_021241
|
WIZ
|
widely interspaced zinc finger motifs
|
|
chr2_-_161058550
|
0.391
|
NM_002897
NM_016836
|
RBMS1
|
RNA binding motif, single stranded interacting protein 1
|
|
chr17_+_26446082
|
0.391
|
|
NF1
|
neurofibromin 1
|
|
chr3_-_14964403
|
0.391
|
|
|
|
|
chr2_+_10101822
|
0.390
|
NM_001177718
|
KLF11
|
Kruppel-like factor 11
|
|
chr1_+_9275542
|
0.390
|
|
SPSB1
|
splA/ryanodine receptor domain and SOCS box containing 1
|
|
chrX_+_152413646
|
0.385
|
|
BGN
|
biglycan
|
|
chr15_+_71763773
|
0.384
|
|
CD276
|
CD276 molecule
|
|
chr3_+_112273464
|
0.383
|
NM_015480
|
PVRL3
|
poliovirus receptor-related 3
|
|
chr5_-_171814026
|
0.383
|
NM_001017995
|
SH3PXD2B
|
SH3 and PX domains 2B
|
|
chr22_-_17546296
|
0.382
|
NM_005984
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
|
chrX_+_153318452
|
0.381
|
NM_001493
|
GDI1
|
GDP dissociation inhibitor 1
|
|
chr15_+_71763830
|
0.380
|
|
CD276
|
CD276 molecule
|
|
chr6_-_41855564
|
0.379
|
NM_006653
|
FRS3
|
fibroblast growth factor receptor substrate 3
|
|
chr9_+_127550298
|
0.378
|
NM_001134778
|
PBX3
|
pre-B-cell leukemia homeobox 3
|
|
chrX_-_19815370
|
0.376
|
|
SH3KBP1
|
SH3-domain kinase binding protein 1
|
|
chr17_+_34114924
|
0.376
|
|
MLLT6
|
myeloid/lymphoid or mixed-lineage leukemia (trithorax homolog, Drosophila); translocated to, 6
|
|
chr12_+_52060689
|
0.375
|
NM_003109
|
SP1
|
Sp1 transcription factor
|
|
chr8_+_136539290
|
0.374
|
|
KHDRBS3
|
KH domain containing, RNA binding, signal transduction associated 3
|
|
chr11_-_9069668
|
0.372
|
NM_001170690
NM_020974
|
SCUBE2
|
signal peptide, CUB domain, EGF-like 2
|
|
chr7_+_101860958
|
0.371
|
NM_001126340
NM_032831
|
ORAI2
|
ORAI calcium release-activated calcium modulator 2
|
|
chr2_+_45732416
|
0.370
|
NM_005400
|
PRKCE
|
protein kinase C, epsilon
|
|
chr9_-_124030770
|
0.368
|
NM_014368
NM_199160
|
LHX6
|
LIM homeobox 6
|
|
chr10_-_105604942
|
0.367
|
NM_014631
|
SH3PXD2A
|
SH3 and PX domains 2A
|
|
chr22_-_17545872
|
0.366
|
|
SLC25A1
|
solute carrier family 25 (mitochondrial carrier; citrate transporter), member 1
|
|
chr14_-_64508547
|
0.363
|
NM_198686
|
RAB15
|
RAB15, member RAS onocogene family
|
|
chr19_-_4408789
|
0.361
|
NM_025241
|
UBXN6
|
UBX domain protein 6
|
|
chr1_-_31485320
|
0.360
|
NM_024522
|
NKAIN1
|
Na+/K+ transporting ATPase interacting 1
|
|
chr10_-_75241347
|
0.359
|
|
NDST2
|
N-deacetylase/N-sulfotransferase (heparan glucosaminyl) 2
|
|
chr9_+_139092016
|
0.357
|
|
UAP1L1
|
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1
|
|
chr19_-_36531958
|
0.357
|
NM_020856
|
TSHZ3
|
teashirt zinc finger homeobox 3
|
|
chr9_+_139091759
|
0.357
|
NM_207309
|
UAP1L1
|
UDP-N-acteylglucosamine pyrophosphorylase 1-like 1
|
|
chr10_-_25281510
|
0.357
|
NM_020200
|
PRTFDC1
|
phosphoribosyl transferase domain containing 1
|
|
chr19_-_13977875
|
0.357
|
|
RFX1
|
regulatory factor X, 1 (influences HLA class II expression)
|
|
chr1_-_3437834
|
0.356
|
|
MEGF6
|
multiple EGF-like-domains 6
|
|
chr15_+_24799174
|
0.356
|
NM_033223
|
GABRG3
|
gamma-aminobutyric acid (GABA) A receptor, gamma 3
|
|
chr11_-_129689669
|
0.356
|
NM_014155
|
ZBTB44
|
zinc finger and BTB domain containing 44
|
|
chr7_+_150390566
|
0.353
|
|
SLC4A2
|
solute carrier family 4, anion exchanger, member 2 (erythrocyte membrane protein band 3-like 1)
|
|
chr18_+_75256954
|
0.353
|
|
NFATC1
|
nuclear factor of activated T-cells, cytoplasmic, calcineurin-dependent 1
|
|
chr5_-_172689111
|
0.352
|
NM_003714
|
STC2
|
stanniocalcin 2
|
|
chr2_+_46623325
|
0.351
|
NM_012249
|
RHOQ
|
ras homolog gene family, member Q
|
